{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:37:31Z","timestamp":1789727851632,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1991,5,1]],"date-time":"1991-05-01T00:00:00Z","timestamp":673056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1991,5,1]],"date-time":"1991-05-01T00:00:00Z","timestamp":673056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1991,5]]},"DOI":"10.1016\/0002-9343(91)90483-e","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T12:38:07Z","timestamp":1086784687000},"page":"S32-S36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S1","title":["Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: Blood pressure control and immunosuppression"],"prefix":"10.1016","volume":"90","author":[{"given":"Matthew R.","family":"Weir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(91)90483-E_BIB1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ki.1990.139","article-title":"Role of endothelin in cyclosporine-induced glomerular dysfunction","volume":"37","author":"Kon","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/0002-9343(91)90483-E_BIB2","first-page":"431","article-title":"Acute cyclosporine induced decrease in GFR is mediated by changes in renal blood flow and renal vascular resistance (abstr)","volume":"29","author":"Jao","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/0002-9343(91)90483-E_BIB3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00007890-198508000-00022","article-title":"Increase in urinary thromboxane B2 in rats caused by cyclosporine","volume":"40","author":"Kawaguchi","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/0002-9343(91)90483-E_BIB4","first-page":"537","article-title":"Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats","volume":"25","author":"Murray","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1016\/0002-9343(91)90483-E_BIB5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-198705000-00022","article-title":"Induction of contraction in isolated rat aorta by cyclosporine","volume":"43","author":"Xue","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/0002-9343(91)90483-E_BIB6","first-page":"F619","article-title":"Effects of calcium antagonists on renal hemodynamics","volume":"249","author":"Loutzenhiser","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/0002-9343(91)90483-E_BIB7","first-page":"178","article-title":"Effects of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II, and vasopressin","volume":"10","author":"Goldberg","year":"1984","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/0002-9343(91)90483-E_BIB8","series-title":"Calcium antagonists and the kidney","first-page":"33","article-title":"The renal hemodynamic effects of calcium antagonists","author":"Loutzenhiser","year":"1990"},{"key":"10.1016\/0002-9343(91)90483-E_BIB9","first-page":"F619","article-title":"Reversal of renal and smooth muscle actions of the thromboxane mimetic U-44069 by diltiazem","volume":"19","author":"Loutzenhiser","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/0002-9343(91)90483-E_BIB10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(88)80331-0","article-title":"Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent","volume":"85","author":"Curtis","year":"1988","journal-title":"Am J Med"},{"issue":"suppl 1","key":"10.1016\/0002-9343(91)90483-E_BIB11","first-page":"45","article-title":"Clinical experience with converting-enzyme inhibitors in hypertension","volume":"10","author":"Weber","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/0002-9343(91)90483-E_BIB12","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinte.1990.00040031707020","article-title":"A comparison of the efficacy and safety of a \u03b2-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks","volume":"150","author":"Saunders","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-9343(91)90483-E_BIB13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcp.1041240121","article-title":"Mitogen and co-mitogen stimulation of lymphocytes inhibited by three Ca++ antagonists","volume":"124","author":"Grier","year":"1985","journal-title":"J Cell Physiol"},{"key":"10.1016\/0002-9343(91)90483-E_BIB14","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.133.6.2904","article-title":"The interference of T cell activation by calcium channel blocking agents","volume":"133","author":"Birx","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/0002-9343(91)90483-E_BIB15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0022-4804(85)90164-7","article-title":"Verapamil inhibition of lymphocyte proliferation and function in vitro","volume":"39","author":"McMillen","year":"1985","journal-title":"J Surg Res"},{"key":"10.1016\/0002-9343(91)90483-E_BIB16","first-page":"471","article-title":"Inhibition of human peripheral blood mononuclear cell function by verapamil (abstr)","volume":"31","author":"Weir","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/0002-9343(91)90483-E_BIB17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00007890-198510000-00021","article-title":"Potentiation of cyclosporine by verapamil in vitro","volume":"40","author":"McMillen","year":"1985","journal-title":"Transplantation"},{"issue":"suppl 2","key":"10.1016\/0002-9343(91)90483-E_BIB18","first-page":"240","article-title":"Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells","volume":"20","author":"Weir","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/0002-9343(91)90483-E_BIB19","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-199104000-00022","article-title":"Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine","author":"Weir","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/0002-9343(91)90483-E_BIB20","first-page":"866","article-title":"Additive inhibitory effect of cyclosporine and verapamil may occur through different mechanisms that may be dependent or independent of the slow calcium channel","volume":"21","author":"Weir","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1016\/0002-9343(91)90483-E_BIB21","series-title":"Some chemical-pharmacologic aspects","first-page":"17","article-title":"Calcium antagonists","volume":"52","author":"Triggle","year":"1983"},{"key":"10.1016\/0002-9343(91)90483-E_BIB22","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.4049\/jimmunol.139.10.3224","article-title":"The inhibitory effects of K+ channel-blocking agents on T lymphocyte proliferation and lymphokine production are \u201cnonspecific\u201d","volume":"139","author":"Schell","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/0002-9343(91)90483-E_BIB23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007890-198212000-00007","article-title":"Late mortality and morbidity in recipients of long-term renal allografts","volume":"34","author":"Kirkman","year":"1982","journal-title":"Transplantation"},{"key":"10.1016\/0002-9343(91)90483-E_BIB24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.1981.125","article-title":"Verapamil disposition kinetics in patients with chronic atrial fibrillation","volume":"30","author":"Kates","year":"1981","journal-title":"J Clin Pharmacol Ther"},{"key":"10.1016\/0002-9343(91)90483-E_BIB25","series-title":"Role of calcium entry blockers","first-page":"313","article-title":"Cellular calcium in ischemic acute renal failure","volume":"32","author":"Schrier","year":"1987"},{"key":"10.1016\/0002-9343(91)90483-E_BIB26","first-page":"1353","article-title":"Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up","volume":"19","author":"Wagner","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/0002-9343(91)90483-E_BIB27","first-page":"575","article-title":"Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil","volume":"48","author":"Dawidson","year":"1989","journal-title":"Transplantation"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439190483E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439190483E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:36:29Z","timestamp":1756884989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/000293439190483E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,5]]}},"alternative-id":["000293439190483E"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(91)90483-e","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1991,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: Blood pressure control and immunosuppression","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(91)90483-E","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1991 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}